# Characteristics of LKDS and PBSS of KOA Based on the Enhancement of Inflammatory Response by TGF-β/Smad Pathway Inhibited

> **NCT05218122** · — · UNKNOWN · sponsor: **Dongzhimen Hospital, Beijing** · enrollment: 340 (estimated)

## Conditions studied

- Knee Osteoarthritis
- Syndrome
- Traditional Chinese Medicine

## Interventions

- **OTHER:** cross-sectional study without intervention

## Key facts

- **NCT ID:** NCT05218122
- **Lead sponsor:** Dongzhimen Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-24
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2022-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05218122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05218122, "Characteristics of LKDS and PBSS of KOA Based on the Enhancement of Inflammatory Response by TGF-β/Smad Pathway Inhibited". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05218122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*